PRODUCT LIFE acquired by 21 INVEST & OAKLEY CAPITAL INVESTMENTS
Context
21 Invest France acquired a majority stake in ProductLife Group from its founder who sought to institutionalize the company and secure resources for its next growth phase. The transaction was structured to allow the management team to reinvest significantly alongside 21 Invest. The strategic roadmap was focused on transforming PLG into an undisputed global leader through massive international consolidation.
PRODUCT LIFE, which reported an EBITDA margin of [members only] in 2023, is valued in this transaction at an EV/EBITDA multiple of [members only], to compare with the average currently observed in the Healthcare & Pharma sector (14.3x).
-> Deep-dive in Healthcare & Pharma market trends
Target
ProductLife Group (PLG) is a specialized global provider of outsourcing and consulting services for the pharmaceutical and life sciences industries. The company focuses on the highly regulated segments of Regulatory Affairs and Pharmacovigilance, supporting drug manufacturers through the entire product lifecycle—from clinical development to market authorization and post-market safety monitoring.
Ent. Value
€500M–1.5bn
Equity Value
[members only]
Multiples
EV / Revenue
2x–6x
EV / EBITDA
[members only]
EV / EBIT
[members only]
Historical Financials (EUR)
Similar deals in Healthcare Services
Similar deals in Healthcare Services
| Date | Acquirer | Target | Country | Sector |
|---|---|---|---|---|
| 07/2024 | ARDIAN | MASCO GROUP | ITALY | Healthcare Services |
| 06/2024 | PERMIRA | PHARMACORD | UNITED STATES | Health Tech |
| 10/2023 | MOTION EQUITY PARTNERS | BANOOK | FRANCE | CRO / Clinical Trials |
| 09/2023 | PERMIRA | ERGOMED | UNITED KINGDOM | CRO / Clinical Trials |
| 09/2023 | CERBA HEALTHCARE | CIRION BIOPHARMA RESEARCH | CANADA | CRO / Clinical Trials |
| 06/2023 | SUPERNOVA INVEST / HEAL CAPITAL | GLEAMER | FRANCE | Health Tech |
| 06/2022 | ASTORG | OPEN HEALTH | UNITED STATES | Healthcare Services |
| 11/2020 | KERSIA | SOPURA | BELGIUM | Sterilization & Hygiene |
| 10/2020 | IK PARTNERS | KERSIA | FRANCE | Sterilization & Hygiene |
| 05/2020 | CLAYTON, DUBILIER & RICE (CD&R) | HUNTSWORTH | UNITED KINGDOM | Healthcare Services |
Other operations with 21 INVEST / OAKLEY CAPITAL INVESTMENTS
| Date | Acquirer | Target | Country | Sector |
|---|---|---|---|---|
| 09/2026 | 21 INVEST | GRUPO CELESA | SPAIN | Special Machinery |
| 06/2026 | 21 INVEST | KALI ENVIRONNEMENT | FRANCE | Engineering & Consulting |
| 12/2025 | 21 INVEST | ParkinGO Group | ITALY | Infrastructure & Ground Services |
| 09/2025 | 21 INVEST / BNP PARIBAS BNL EQUITY / FONDO ITALIANO DI INVESTIMENTO | ELSE SOLUTIONS | ITALY | Diagnostic Equipment |
| 11/2023 | 21 INVEST | CONEX | FRANCE | Industry-Specific Software |
| 04/2019 | 21 INVEST | FMA GROUP (FMA ASSURANCES) | FRANCE | Brokerage |
| 04/2014 | 21 INVEST | FORNO D’ASOLO | ITALY | Bakery / Pastry |
| 05/2007 | 21 INVEST | SUD ROBINETTERIE INDUSTRIE | FRANCE | Valves, Pumps & Taps |
REFERENCES
Valuation range: EV €500M–1.5bn
Revenue range: €100–200M
EV/Revenue range: 2x - 6x
Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of PRODUCT LIFE by 21 INVEST / OAKLEY CAPITAL INVESTMENTS are reserved for mynth community members. Register for free to unlock full data.
Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.
Acquirer: 21 invest / oakley capital investments